Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Aug 2026 for Galectin Therapeutics INC, €9.0M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard E. Uihlein: trading record in brief
Richard E. Uihlein (board member) discloses dealings in Galectin Therapeutics Inc to SEC (Form 4). Between 24 January 2022 and 31 July 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 4 August 2026, the filings show an option exercise worth €82.9M in Galectin Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard E. Uihlein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,550,932 shares@ US$4.052.96% mcap9.1% of flowCommon StockSEC:0001133416-26-000065:1
31,825,235 shares@ US$3.0027.36% mcap83.8% of flowCommon StockSEC:0001133416-26-000065:0
13,158 shares@ US$3.040.5% of flowCommon StockSEC:0001133416-26-000020:0
32,520 shares@ US$1.230.5% of flowCommon StockSEC:0001133416-25-000022:0
23,256 shares@ US$1.720.5% of flowCommon StockSEC:0001133416-24-000026:0
1,466,204 shares@ US$5.0098.6% of flowCommon StockSEC:0001133416-23-000075:0
36,036 shares@ US$1.110.5% of flowCommon StockSEC:0001133416-23-000008:0
17,677 shares@ US$1.980.4% of flowCommon StockSEC:0001133416-22-000043:0
8 of 8 declarations
